These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35895363)

  • 21. Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.
    Grifoni A; Pham J; Sidney J; O'Rourke PH; Paul S; Peters B; Martini SR; de Silva AD; Ricciardi MJ; Magnani DM; Silveira CGT; Maestri A; Costa PR; de-Oliveira-Pinto LM; de Azeredo EL; Damasco PV; Phillips E; Mallal S; de Silva AM; Collins M; Durbin A; Diehl SA; Cerpas C; Balmaseda A; Kuan G; Coloma J; Harris E; Crowe JE; Stone M; Norris PJ; Busch M; Vivanco-Cid H; Cox J; Graham BS; Ledgerwood JE; Turtle L; Solomon T; Kallas EG; Watkins DI; Weiskopf D; Sette A
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T Cell Responses to Nonstructural Protein 3 Distinguish Infections by Dengue and Zika Viruses.
    Herrera BB; Tsai WY; Brites C; Luz E; Pedroso C; Drexler JF; Wang WK; Kanki PJ
    mBio; 2018 Aug; 9(4):. PubMed ID: 30087165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey.
    Nguyen CT; Moi ML; Le TQM; Nguyen TTT; Vu TBH; Nguyen HT; Pham TTH; Le THT; Nguyen LMH; Phu Ly MH; Ng CFS; Takemura T; Morita K; Hasebe F
    BMC Infect Dis; 2020 May; 20(1):332. PubMed ID: 32393198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.
    Dejnirattisai W; Supasa P; Wongwiwat W; Rouvinski A; Barba-Spaeth G; Duangchinda T; Sakuntabhai A; Cao-Lormeau VM; Malasit P; Rey FA; Mongkolsapaya J; Screaton GR
    Nat Immunol; 2016 Sep; 17(9):1102-8. PubMed ID: 27339099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-Reactive Dengue Virus Antibodies Augment Zika Virus Infection of Human Placental Macrophages.
    Zimmerman MG; Quicke KM; O'Neal JT; Arora N; Machiah D; Priyamvada L; Kauffman RC; Register E; Adekunle O; Swieboda D; Johnson EL; Cordes S; Haddad L; Chakraborty R; Coyne CB; Wrammert J; Suthar MS
    Cell Host Microbe; 2018 Nov; 24(5):731-742.e6. PubMed ID: 30439342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of prior dengue virus infection on Zika virus infection during pregnancy in marmosets.
    Kim IJ; Tighe MP; Clark MJ; Gromowski GD; Lanthier PA; Travis KL; Bernacki DT; Cookenham TS; Lanzer KG; Szaba FM; Tamhankar MA; Ross CN; Tardif SD; Layne-Colon D; Dick EJ; Gonzalez O; Giraldo Giraldo MI; Patterson JL; Blackman MA
    Sci Transl Med; 2023 Jun; 15(699):eabq6517. PubMed ID: 37285402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zika Virus Antibody Titers Three Years after Confirmed Infection.
    Langerak T; Kasbergen LMR; Chandler F; Brinkman T; Faerber Z; Phalai K; Ulbert S; Rockstroh A; Bruin E; Koopmans MPG; Rockx B; van Gorp ECM; Vreden S
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection.
    Bonheur AN; Thomas S; Soshnick SH; McGibbon E; Dupuis AP; Hull R; Slavinski S; Del Rosso PE; Weiss D; Hunt DT; McCabe ME; Dean AB; Folkerth R; Laib AM; Wong SJ
    BMC Infect Dis; 2021 Aug; 21(1):749. PubMed ID: 34348665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The seroepidemiology of dengue in a US military population based in Puerto Rico during the early phase of the Zika pandemic.
    Pollett S; Kuklis CH; Barvir DA; Jarman RG; Romaine RM; Forshey BM; Gromowski GD
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0009986. PubMed ID: 35061659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-existing T Cell Memory against Zika Virus.
    Schouest B; Grifoni A; Pham J; Mateus J; Sydney J; Brien JD; De Silva AD; Balmaseda A; Harris E; Sette A; Weiskopf D
    J Virol; 2021 May; 95(12):. PubMed ID: 33789994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Previous dengue or Zika virus exposure can drive to infection enhancement or neutralisation of other flaviviruses.
    Oliveira RA; de Oliveira-Filho EF; Fernandes AI; Brito CA; Marques ET; Tenório MC; Gil LH
    Mem Inst Oswaldo Cruz; 2019; 114():e190098. PubMed ID: 31411310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zika Virus and the World Health Organization Criteria for Determining Recent Infection Using Plaque Reduction Neutralization Testing.
    Ward MJ; Alger J; Berrueta M; Bock H; Buekens P; Cafferata ML; Ciganda A; García J; García K; Lopez W; Lorenzana I; Parham L; Wesson DM
    Am J Trop Med Hyg; 2018 Sep; 99(3):780-782. PubMed ID: 29943723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection.
    Valiant WG; Huang YS; Vanlandingham DL; Higgs S; Lewis MG; Mattapallil JJ
    Emerg Microbes Infect; 2018 Jul; 7(1):130. PubMed ID: 30006514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survey on neutralizing antibodies against Zika virus eighteen months post-outbreak in two southern Thailand communities.
    Densathaporn T; Sangthong R; Sakolnapa M; Surasombatpattana S; Kemapunmanus M; Masrinoul P; Yoksan S; McNeil EB; Chongsuvivatwong V
    BMC Infect Dis; 2020 Dec; 20(1):921. PubMed ID: 33272192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
    Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
    Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Evaluation of Differential Serodiagnosis between Zika and Dengue Viral Infections.
    Chao DY; Whitney MT; Davis BS; Medina FA; Munoz JL; Chang GJ
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30541932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An epidemiological survey of the current status of Zika and the immune interaction between dengue and Zika infection in Southern Taiwan.
    Wang WH; Urbina AN; Wu CC; Lin CY; Thitithanyanont A; Assavalapsakul W; Lu PL; Chen YH; Wang SF
    Int J Infect Dis; 2020 Apr; 93():151-159. PubMed ID: 31982624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-Existing Dengue Immunity Drives a DENV-Biased Plasmablast Response in ZIKV-Infected Patient.
    Bhaumik SK; Priyamvada L; Kauffman RC; Lai L; Natrajan MS; Cho A; Rouphael N; Suthar MS; Mulligan MJ; Wrammert J
    Viruses; 2018 Dec; 11(1):. PubMed ID: 30597938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.